“Top AI Biotech Stocks Set To Explode 2026”
RXRX is a high-risk moonshot with potential upside from AI-driven drug discovery, but faces volatility and unreliable sales until a commercial hit occurs.
All right, guys. Um, it's time to wrap up the list, though, with um stock number three now, which is actually going to be our riskiest option of the three. Um, and it's kind of a moonshot play, uh, the moonshot option of the bunch, and that is Recursion Pharmaceuticals, ticker symbol RXRX,